166 related articles for article (PubMed ID: 7534811)
1. Antibodies to parvovirus B19 NS-1 protein in infected individuals.
von Poblotzki A; Gigler A; Lang B; Wolf H; Modrow S
J Gen Virol; 1995 Mar; 76 ( Pt 3)():519-27. PubMed ID: 7534811
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
von Poblotzki A; Hemauer A; Gigler A; Puchhammer-Stöckl E; Heinz FX; Pont J; Laczika K; Wolf H; Modrow S
J Infect Dis; 1995 Nov; 172(5):1356-9. PubMed ID: 7594677
[TBL] [Abstract][Full Text] [Related]
3. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
4. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
Dobec M; Juchler A; Flaviano A; Kaeppeli F
Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
[TBL] [Abstract][Full Text] [Related]
5. Impaired gamma interferon responses against parvovirus B19 by recently infected children.
Corcoran A; Doyle S; Waldron D; Nicholson A; Mahon BP
J Virol; 2000 Nov; 74(21):9903-10. PubMed ID: 11024117
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses in parvovirus B19 infected patients.
Modrow S; Dorsch S
Pathol Biol (Paris); 2002 Jun; 50(5):326-31. PubMed ID: 12116851
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
Bostic JR; Brown KE; Young NS; Koenig S
J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
Jones LP; Erdman DD; Anderson LJ
J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
12. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients.
Speyer I; Breedveld FC; Dijkmans BA
Clin Exp Rheumatol; 1998; 16(5):576-8. PubMed ID: 9779306
[TBL] [Abstract][Full Text] [Related]
13. Detection of IgE anti-parvovirus antibodies in human breast milk.
Smith-Norowitz TA; Drew H; Norowitz HM; Nowakowski M; Bluth EF; Durkin HG; Bluth MH
Ann Clin Lab Sci; 2008; 38(2):168-73. PubMed ID: 18469364
[TBL] [Abstract][Full Text] [Related]
14. Association between human parvovirus B19 infection and arthritis.
Cassinotti P; Bas S; Siegl G; Vischer TL
Ann Rheum Dis; 1995 Jun; 54(6):498-500. PubMed ID: 7632094
[TBL] [Abstract][Full Text] [Related]
15. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
Kerr JR; Coyle PV; DeLeys RJ; Patterson CC
J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
[TBL] [Abstract][Full Text] [Related]
16. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19-induced chronic arthropathy in a child.
Lopreiato JO; Katona IM
Clin Pediatr (Phila); 1993 May; 32(5):305-7. PubMed ID: 8324977
[No Abstract] [Full Text] [Related]
18. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
Gray JJ; Cohen BJ; Desselberger U
J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
[TBL] [Abstract][Full Text] [Related]
19. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F
AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
